首页 | 本学科首页   官方微博 | 高级检索  
     

绝经前后妇女子宫内膜癌临床病理分析
引用本文:彭丽秀,周昌菊. 绝经前后妇女子宫内膜癌临床病理分析[J]. 医学临床研究, 2009, 26(4): 570-573
作者姓名:彭丽秀  周昌菊
作者单位:中南大学湘雅三医院妇产科,湖南,长沙,410013
基金项目:湖南省科技厅资助项目,湖南省卫生厅立项课题 
摘    要:【目的】分析未绝经和绝经后妇女子宫内膜癌的临床病理特征。【方法】采用回顾性分析法,将53例内膜癌患者根据绝经与否分为未绝经组34例,绝经组19例,分析比较两组的发病因素、病程、临床表现、病理组织类型及雌、孕激素受体的表达。【结果】未绝经组与绝经组均以不规则阴道流血为主要表现,分别为88.2%、79.0%;未绝经组确诊时间(610.9±145.5)d,显著长于绝经组的(104.1±27.1)d(P〈0.05);未绝经组子宫内膜样癌占97.1%,显著高于绝经组的78.8%,而非子宫内膜样癌占2.9%,低于绝经组的21.1%(P〈0.05);两组在肿瘤病理组织学分级均差异无显著性(P〉0.05);在临床分期间未绝经组Ⅱ期占5.9%,明显低于绝经组的42.1%,而Ⅲ期患者占32.4%,显著高于绝经组的5.3%(P〈0.05);雌、孕激素受体表达在两组间差异无显著性(P〉0.05);雌、孕激素受体阳性表达率I期高于Ⅱ~Ⅲ期(P〈0.05);雌、孕激素受体表达呈正相关关系,雌、孕激素受体与临床分期分别呈负相关关系(P〈0.05)。【结论】子宫内膜癌绝经前、后妇女均以不规则阴道流血为主要的临床表现;I型内膜癌占绝经前、后妇女的绝大多数;雌、孕激素受体可作为内膜癌预后的监测指标;重视绝经前妇女不规则阴道流血是其早期诊断的关键。

关 键 词:子宫内膜肿瘤/病理学  绝经前期  绝经后期

Analysis on Clinicopathologic Features in Patients with Endometrial Cancer Before and after Menopause
PENG Li-Xiu,ZHOU Chang-Ju. Analysis on Clinicopathologic Features in Patients with Endometrial Cancer Before and after Menopause[J]. Journal of Clinical Research, 2009, 26(4): 570-573
Authors:PENG Li-Xiu  ZHOU Chang-Ju
Affiliation:(Department of Gynaecology & Obstetrics, Third Xiangya Hospital, Central South University, Changsha 410013, China)
Abstract:[Objective]To analyze the clinicopathologic features in patients with endometrial cancer before and after menopause. [Methods]The etiopathogenisis, course, clinical manifestation, pathology, estrogen and progesterone receptor between pre-menopausat group(n =34) and post-menopausal group(n=19) were analyzed and compared retrospectively. [Results]Irregular colporrhagia was the chief appearance in the pre-mena- pausal and post-menapausal groups, and the incidence rate was 88.2 % and 79.9 %, respectively. Final diagnosis time was longer in pre-menopausal group(610.9±145. 5 days) than that in the post-menopausal group (104.1±27.1days)(P〈0.05). There were 97.1% endometrioid cancer in the pre-menopausal group and 78. 8% endometrioid cancer in the post-menopausal group, and 2.9 % non-endometrioid cancer in the pre-menopa- usal group and 21.1% non-endometrioid cancer in the post-menopausal group. There was no difference in the tumor grades between pre-menopausal group and post-menopausal group(P〉0.05). There were 5.9% cases with stage Ⅱ and 32.4% with stage Ⅲ in the pre-menopausal group, but there were 42.1% cases with stage Ⅱ and 5.3% cases with stage Ⅲ , and there was significant difference between the two groups( P〈0.05). There was no difference in the expression of the estrogen/progesterone receptor between the two groups(P〉0.05). The expression of estrogen/progesterone receptor in stage I was higher than that in stage Ⅱ and stage Ⅲ(P〈0.05). There was a positive correlation between estrogen receptor and progesterone receptor( P 〈0.05), and a negative correlation between estrogen/progesterone receptor and the operation-pathology stage (P〈0.05). [Conclusion] Irregular colporrhagia is the chief clinical appearance. Most patients are type I endometrial cancer. Estrogen/progesterone receptor is a good prognostic factor. Paying more attention to irregular colporrhagia in pre-menopausal women is important for early diagnosis.
Keywords:endometrial neoplasms/PA  premenopause  postmenopause
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号